ABSTRACT Inhibition of the adenylate cyclase activity in homogenates of mouse neuroblastoma-glioma hybrid cells (NG108-15) by the opioid peptide [-Ala2,Metsjenkephalin amide (AMEA) requires the presence of Na+ and GTP. In this process, the selectivity for monovalent cations is Na+ > Li+ > K+ > choline+; ITP will replace GTP but ATP, UTP, or CTP will not. The apparent Km for Na+ is 20 mM and for GTP it is I .&M. Under saturating Na+ and GTP conditions, the apparent Ki for AMEA-directed inhibition is 20 nM for basal and 100 nM for prostaglandin E1-activated adenylate cyclase activity. For both cyclase activities, maximal inhibition is only partial (i.e., -55% of control in each case). In intact viable NG108-15 cells, the decrease in basal and prostaglandin El-stimulated intracellular cyclic AMP concentrations by AMEA is also dependent upon extracellular Na+. Thee ephalin-directed reductions in cyclic AMP co riss are at least 75%. The specificity of the monovalent cation requirement for enkephalin action on intact cells is the same as for enkephalin regulation of homogenate adenylate cyclase activity. Based on these data, a model is presented in which the transfer of information from opiate receptors to adenylate cyclase requires active separate membrane components, which correspond to the sites of action of Na+ and GTP in this process. Opiates decrease the intracellular cyclic AMP (cAMP) concentrations of intact mouse neuroblastoma-rat glioma hybrid cells (NG108-15) by inhibiting the activity of the adenylate cyclase of these cells (1-3). This regulation of cAMP requires occupation of highly specific receptors by opiate agonists and is blocked by opiate antagonists. Recently, these opiate receptors were found to be sensitive to guanine nucleotides (4, 5) and Na+ (4-7). The effects of Na+ and nucleotides on NG108-15 opiate receptors parallel the effects of Na+ (8-14) and nucleotides (15, 16) on brain opiate receptors. Although nucleotides and Na+ have nonspecific effects on NG108-15 and brain opiate receptors, the actions of ions and nucleotides can be used to discriminate between agonist and antagonist interactions with opiate receptors.
cyclic AMP concentrations by AMEA is also dependent upon extracellular Na+. Thee ephalin-directed reductions in cyclic AMP co riss are at least 75%. The specificity of the monovalent cation requirement for enkephalin action on intact cells is the same as for enkephalin regulation of homogenate adenylate cyclase activity. Based on these data, a model is presented in which the transfer of information from opiate receptors to adenylate cyclase requires active separate membrane components, which correspond to the sites of action of Na+ and GTP in this process. Opiates decrease the intracellular cyclic AMP (cAMP) concentrations of intact mouse neuroblastoma-rat glioma hybrid cells (NG108-15) by inhibiting the activity of the adenylate cyclase of these cells (1) (2) (3) . This regulation of cAMP requires occupation of highly specific receptors by opiate agonists and is blocked by opiate antagonists. Recently, these opiate receptors were found to be sensitive to guanine nucleotides (4, 5) and Na+ (4) (5) (6) (7) . The effects of Na+ and nucleotides on NG108-15 opiate receptors parallel the effects of Na+ (8) (9) (10) (11) (12) (13) (14) and nucleotides (15, 16 ) on brain opiate receptors. Although nucleotides and Na+ have nonspecific effects on NG108-15 and brain opiate receptors, the actions of ions and nucleotides can be used to discriminate between agonist and antagonist interactions with opiate receptors.
The selective nucleotide and ion regulation of agonist interactions with opiate receptors is reminiscent of the welldocumented guanine nucleotide regulation of agonist interaction with hormonal receptors that mediate activations of adenylate cyclase (17) (18) (19) (20) . In the latter case, agonist occupation of the receptor can take place without any nucleotides present; however, in order for the agonist-receptor complex to cause an increase in adenylate cyclase activity, the presence of a guanine nucleotide is required. Biochemical (21) , genetic (22, 23) , cell fusion (24, 25) , and reconstitution (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) studies have shown that the receptor and catalytic units of adenylate cyclase are separate proteins and that another membrane component(s) (here termed the "coupler") is actually required for receptordirected activation of the catalytic unit.
The published observations of Na+ and nucleotide sensitivity of opiate-agonist binding therefore raise the possibility that Na+ as well as guanine nucleotides may be required for opiate receptor-mediated regulation of NG108-15 adenylate cyclase. We report here our findings of an absolute dependence upon the presence of both Na+ and guanine nucleotides for opiate inhibition of NG108-15 adenylate cyclase.
MATERIALS AND METHODS
Membrane Preparations of Adenylate Cyclase. The source of adenylate cyclase in all these studies was the mouse neuroblastoma-rat glioma hybrid NG108-15 (passage no. . Cells were maintained in Dulbecco's modified Eagle's medium with 10% fetal calf serum, hypoxanthine, aminopterin, and thymidine as described (1) (2) (3) (4) about half-maximal inhibition of basal activity was observed in the presence of 135 mM Na+ without added GTP. With the PGEI-stimulated activity, addition of Na+ (but not GTP) allowed 86% of the maximal possible opioid inhibition.
With nuclei-and supernatant-free NG108-15 membranes, a clear requirement for added Na+ and GTP for maximal oplioid inhibition was observed (Table 2) . Basal activity was now < 10% inhibited by enkephalin when either Na+ or GTP was added alone; the full 50% inhibition was evident when both Na+ and GTP were present. In addition, the PGEI-activated enzyme was only slightly inhibitable (i.e., 27% of maximal inhibition) when Na+ was added by itself. In these preparations, etorphine and morphine also inhibited basal and PGEI-stimulated activity to a similar partial extent (i.e., -50%) and their action was likewise dependent upon the presence of Na+ and GTP (data not shown).
As expected from the work of Nirenberg and coworkers (1-3), the opiate antagonists naloxone and naltrexone blocked all opiate and enkephalin inhibition of adenylate cyclase under our assay conditions (see Fig. 4 ).
It is important to point out that the requirement for "added" Na+ could be seen only when the Tris salt of creatine phosphate was used as part of the nucleotide triphosphate-regenerating system in the assay mixtures. The commonly purchased creatine phosphate is a Na2 salt and therefore by itself makes the endogenous contents of these assays 40 mM Na+. This amount of Na+ is twice as great as needed to allow for half-maximal enkephalin inhibition (Fig. 1) . Furthermore, the ATP used here was made by phosphorylation of adenosine and did not contain enough GTP to obscure adenylate cyclase regulation otherwise dependent upon added GTP (34) .
The question arises as to whether or not the requirement for Na+ is related to the known Na+ regulation of NG108-15 opiate receptors (4, 5) . As reported (5), AMEA binding affinity is selectively decreased by monovalent cations with a potency order of Na+ > Li+ > K > choline+ and with an apparent Km for Na+ of z20 mM. The observed concentration curve for the Na+ required for opiate-directed inhibition of NG108-15 adenylate cyclase appears narrow (perhaps indicating a cooperative type of action) and has an apparent Km value of t20 mM (Fig. 1 ). Lithium appears to be slightly less effective, K+ considerably less effective, and choline+ least effective [only 9% of maximal opiate inhibition was observed with 75 mM choline (Table  3) ]. Assays were conducted on the resuspended membranes that had been pelleted at 40,000 X g after a 30-min centrifugation of the nuclei-free NG108-15 homogenates described in Table 1 . Where indicated, NaCl (0.135 M), GTP (0.1 mM), and PGE1 (1 MuM) were added to the standard Na+-free assay mixture.
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; /I (aa0t0 10- (Fig. 3) . Investigation of the specificity of action of nucleotide triphosphates in this phenomenon revealed that ITP, but not UTP, CTP, or ATP, could replace GTP (Table 4) . Our earlier studies on opiate binding to NG108-15 receptors showed that GDP also regulates these opiate receptors (4, 5) . The possible effectiveness of GDP as a coupler could not be ascertained because a nucleotide triphosphate-regenerating system is present in the adenylate cyclase assay mixtures in order to maintain constant substrate levels of ATP. Nevertheless, the question of whether GDP can replace GTP for opiate coupling as it does for regulating opiate binding is certainly important.
Although both basal and activated adenylate cyclase were inhibited to a similar partial extent (Table 2 ; Fig. 4) , we wondered whether or not these two enzyme states were equally susceptible to opiate inhibition. Analysis of AMEA inhibition of basal and PGEI-stimulated enzyme (Fig. 4) showed that less opiate was required to inhibit 50% of basal (apparent Ki e20 nM) than 50% of PGE1-stimulated (apparent Ki = 100 nM) activity. Both inhibitory events, however, appear to be non- (Inset) Plot of the difference in basal enzyme activities with and without AMEA at increasing GTP concentrations, taking the activity observed at each GTP concentration with AMEA to be 100%.
cooperative because their Hill coefficients are nt1.0. This latter finding is not in agreement with the published data of Sharma et al. (2) which showed basal activity to be inhibitable in a positively cooperative manner by a number of opiate agonists. The differences observed might be due to the fact that our assays were done at 32°C on membranes preequilibrated with opiates and in the presence of saturating Na+ and GTP. The studies by Sharma et al. were done at 370C on total crude homogenates at less than saturating Na+ with no added GTP and without preequilibration with opiates before initiation of the cyclase assays.
After observing that both Na+ and guanine nucleotide regulation of opiate binding are apparently related to the coupling of opiate receptors and adenylate cyclase, we decided to investigate the influence of the divalent cations on coupling. We proceeded in this direction because both Mg2+ and Mn2+ had been shown to reverse Na+-induced alterations in opiate binding [with both rat brain (36) (37) (38) and NG108-15 opiate receptors (4-7)]. In our studies, increasing Mg2+ above 12 mM or addition of > 1.0mM Mn2+ in the presence of 10 mM Mg2+ eliminated the ability of opiates to inhibit basal or PGE1-stimulated adenylate cyclase (data not shown). Increased Mg2+ or Mn2+ therefore produces "states" of the cyclase which, along with the NaF and guanyl-5'-ylimidodiphosphate, "states" of the enzyme (2), are not significantly susceptible to opiate inhibition. However, it remains to be proven if these effects of The results presented here conclusively show that Na+ and GTP are required for opiate inhibition of NG108-15 adenylate cyclase. A guanine nucleotide requirement for receptor-directed inhibition of adenylate cyclase appears to be a general phenomenon. It is also present for muscarinic cholinergic (unpublished data) and a-adrenergic receptor-directed (28) inhibitions of NG108-15 adenylate cyclase and adenosine receptor-directed inhibitions of the fat cell adenylate cyclase (39) .
In agreement with the idea that all these inhibitions are produced through a similar regulatory process is the observation that opiate, a-adrenergic, and muscarinic inhibitions of NG108-15 adenylate cyclase are not additive (28) and that Na+ is required for opiate as well as muscarinic and adenosine inhibition of adenylate cyclase (see later in Discussion). The discovery of the need for a guanine nucleotide for receptor-directed inhibition of adenylate cyclase does not come as a surprise, because all known hormonal receptor-mediated activations of adenylate cyclase require the presence of guanine nucleotides. In both cases: (i) GTP and ITP allow functional coupling, whereas ATP, UTP, and CTP do not; (ii) GTP and ITP decrease the affinity of agonist ligands for their specific receptors; and (iii) once fully activated by guanyl-5'-yl imidodiphosphate, the cyclase is no longer "regulatable" by the receptor. However, the apparent Km for GTP in the activation process appears to be much lower than it is in the inhibitory process. Work by many investigators (26, 27, (40) (41) (42) (43) (44) indicates that the site of action of guanine nucleotides in the activation process is on a separate membrane unit (coupler) that confers not only receptor but also NaF, divalent cation, and cholera toxin sensitivity to the catalytic unit of adenylate cyclase. It appears likely that some type of coupler is also involved in transferring inhibitory information from plasma membrane receptors to the adenylate cyclase.
The processes of transferring inhibitory and excitatory information from receptors to adenylate cyclase are clearly differentiated because Na+ is apparently only involved in the inhibitory process. Because Na+ is also required for muscarinic inhibition of NG108-15 (unpublished data) and adenosine inhibition of the fat cell adenylate cyclase (C. Londos, personal communication), we propose that there is another coupler function (or another coupler) within plasma membranes. This entity would be not only the site through which Na+ regulates receptors but also the site through which Na+ mediates the receptor-directed inhibitions of the catalytic unit of adenylate cyclase. At present, we cannot distinguish whether Na+ and guanine nucleotides interact with the same or different couplers.
In conclusion, the fact that such a requirement is exhibited by intact cells indicates that Na+ regulation is not an artifact of membrane preparations but is a physiologically important phenomenon. Finally, whether or not all of the central nervous system receptors that recently have been shown to exhibit a similar agonist-specific Na+ (and GTP) sensitivity can initiate a response via a coupling to adenylate cyclase remains to be determined.
